Awọn iroyin Ile-iṣẹ
-
Oogun ti a fojusi fun itọju myelofibrosis: Ruxolitinib
Myelofibrosis (MF) ni a tọka si bi myelofibrosis.O tun jẹ arun ti o ṣọwọn pupọ.Ati idi ti pathogenesis rẹ ko mọ.Awọn ifarahan ile-iwosan ti o wọpọ jẹ sẹẹli ẹjẹ pupa ọmọde ati ẹjẹ granulocytic ọmọde pẹlu nọmba ti o ga julọ ti yiya silẹ sẹẹli ẹjẹ pupa…Ka siwaju -
O yẹ ki o mọ o kere ju awọn aaye 3 wọnyi nipa rivaroxaban
Gẹgẹbi anticoagulant ti ẹnu tuntun, rivaroxaban ti ni lilo pupọ ni idena ati itọju arun thromboembolic iṣọn-ẹjẹ ati idena ikọlu ni fibrillation atrial ti kii-valvular.Lati le lo rivaroxaban diẹ sii ni idi, o yẹ ki o mọ o kere ju awọn aaye 3 wọnyi….Ka siwaju -
Changzhou Pharmaceutical gba ifọwọsi lati ṣe agbejade awọn agunmi Lenalidomide
Changzhou Pharmaceutical Factory Ltd., oniranlọwọ ti Shanghai Pharmaceutical Holdings, gba Iwe-ẹri Iforukọsilẹ Oògùn (Iwe-ẹri No.Ka siwaju -
Kini awọn iṣọra fun awọn tabulẹti rivaroxaban?
Rivaroxaban, bi ajẹkokoro ẹnu ẹnu tuntun, ti jẹ lilo pupọ ni idena ati itọju awọn arun thromboembolic iṣọn-ẹjẹ.Kini MO nilo lati san ifojusi si nigbati o mu rivaroxaban?Ko dabi warfarin, rivaroxaban ko nilo ibojuwo ti didi didi itọka ...Ka siwaju -
2021 FDA Tuntun Oògùn Ifọwọsi 1Q-3Q
Innovation ṣe ilọsiwaju ilọsiwaju.Nigba ti o ba de si ĭdàsĭlẹ ninu idagbasoke ti titun oloro ati mba awọn ọja ti ibi, FDA ká Center fun Oògùn Igbelewọn ati Iwadi (CDER) atilẹyin awọn elegbogi ile ise ni gbogbo igbese ti awọn ilana.Pẹlu oye rẹ ti ...Ka siwaju -
Awọn idagbasoke aipẹ ti Sugammadex iṣuu soda ni akoko jiji ti akuniloorun
Sugammadex Sodium jẹ alatako aramada ti yiyan awọn isinmi iṣan ti kii-depolarizing (myorelaxants), eyiti o jẹ ijabọ akọkọ ninu eniyan ni ọdun 2005 ati pe o ti lo ni ile-iwosan ni Yuroopu, Amẹrika ati Japan.Ti a ṣe afiwe pẹlu awọn oogun anticholinesterase ibile…Ka siwaju -
Awọn èèmọ wo ni thalidomide munadoko ninu itọju!
Thalidomide munadoko ninu atọju awọn èèmọ wọnyi!1. Ninu eyiti awọn èèmọ to lagbara le ṣee lo thalidomide.1.1.ẹdọfóró akàn.1.2.Akàn pirositeti.1.3.nodal rectal akàn.1.4.arun ẹdọ ẹdọforo.1.5.Akàn inu....Ka siwaju -
Ifihan Guangzhou API ni 2021
Awọn 86th China International Pharmaceutical Raw Materials/Intermediates/Packing/Equipment Fair (API China fun kukuru) Ọganaisa: Reed Sinopharm Exhibition Co., Ltd. Akoko ifihan: May 26-28, 2021 Ibi isere: China Import and Export Fair Complex (Guangzhou) Iwọn ifihan: 60,000 square mita Ex...Ka siwaju -
Obeticolic acid
Ni Oṣu Karun ọjọ 29, Intercept Pharmaceuticals kede pe o ti gba ohun elo oogun tuntun pipe lati ọdọ US FDA nipa FXR agonist obeticholic acid (OCA) fun fibrosis ti o fa nipasẹ lẹta Idahun steatohepatitis ti kii-ọti-lile (NASH) (CRL).FDA sọ ninu CRL ti o da lori data…Ka siwaju -
Remdesivir
Ni Oṣu Kẹwa ọjọ 22, akoko ila-oorun, US FDA fọwọsi ni ifowosi Gilead's antiviral Veklury (remdesivir) fun lilo ninu awọn agbalagba ti o jẹ ọdun 12 ati agbalagba ati iwuwo o kere ju 40 kg ni iwulo ile-iwosan ati itọju COVID-19.Gẹgẹbi FDA, Veklury lọwọlọwọ jẹ COVID-19 ti o fọwọsi FDA nikan…Ka siwaju -
Akiyesi ifọwọsi fun Calcium Rosuvastatin
Laipẹ, Nantong Chanyoo ti ṣe iṣẹlẹ pataki miiran ninu itan-akọọlẹ!Pẹlu awọn akitiyan fun ọdun diẹ sii, KDMF akọkọ ti Chanyoo ti ni ifọwọsi nipasẹ MFDS.Gẹgẹbi olupese ti o tobi julọ ti Calcium Rosuvastatin ni Ilu China, a fẹ lati ṣii ipin tuntun ni ọja Korea.Ati awọn ọja diẹ sii yoo b...Ka siwaju -
Iwe-ẹri Iforukọsilẹ (Rosuvastatin)
Ka siwaju
